RAV12

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerNCT00625586MacroGenicsPhase 2Terminated2009-01-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.